Risk factor
Low price volatility
Profitability factor
Very strong margins and returns
About
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.
Target Price
The average target price of NATCOPHARM.NS is 957 and suggests 15% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t
Buy
Sell